Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Apr 17, 2026

Intrepid Potash (IPI): -12% Pullback in 30 Days After +4% Quarterly Gain

Key Takeaways

  • IPI declined approximately 12% over the past 30 days, pulling back from mid-March highs amid profit-taking and softer commodity sentiment.
  • Over the past quarter, the stock rose about 4%, buoyed by a strong Q4 earnings report and rising fertilizer demand.
  • Key drivers include potash segment performance, agricultural input demand, and macroeconomic factors like global fertilizer prices.
  • Volatility stemmed from a March rally to near $49 before recent declines.
  • Upcoming Q1 2026 earnings could influence near-term direction.

Understanding Intrepid Potash (IPI) and Its Market Exposure

Intrepid Potash, Inc. (IPI) offers investors direct exposure to the potash and specialty fertilizer markets. Operating primarily in the agricultural inputs sector within basic materials, the company produces muriate of potash—a key fertilizer—along with Trio, a specialty fertilizer blending potassium, sulfate, and magnesium, and related products like salt and magnesium chloride for industrial and oilfield uses. Potash production drives the majority of revenue, complemented by Trio and oilfield solutions segments. From what I see, this focused exposure to fertilizer commodities is a big reason for IPI's recent price swings, as global potash demand and prices have a direct impact on its performance.

IPI Price Performance: 30 Days Versus the Quarter

In the last 30 days, IPI dropped -11.9%, moving from a close of $40.05 on March 18, 2026, to $35.32 on April 17, 2026. The path was volatile and downward-trending, with a peak around $48 in mid-March followed by a steady decline and range-bound trading in early April.

Looking at the past quarter, IPI managed a +3.9% gain, rising from $34.00 on January 17, 2026, to $35.32. Early March brought sharp upside before the pullback, mirroring broader sector momentum that has since softened.

Key Factors Behind IPI's 30-Day Decline

The 30-day drop came after a mid-March peak, driven initially by momentum from strong Q4 2025 results and expansion news—shares surged over 10% in early March on earnings that beat expectations and solid potash demand. Profit-taking followed, worsened by potential softening in potash prices and weaker commodity sentiment overall. IPI's core potash segment encountered headwinds from stabilizing fertilizer markets after earlier geopolitical rallies. An April 2 announcement of a $70 million sale of Intrepid South Ranch offered some lift but couldn't reverse the downtrend. I also checked this using Tickeron’s AI Screener to see how it stacks up against peers, and outfits like CF Industries and MOS showed similar volatility, pointing to sector-wide pressures.

What Propelled IPI Over the Quarter

IPI's modest quarterly gain stemmed from solid Q4 results in early March, which showed revenue growth and narrowed losses, plus stronger demand for domestic potash amid global supply worries. The stock climbed sharply from February lows near $32 to $48 by March 12, fueled by positive analyst views and tailwinds in the fertilizer sector, such as growing agricultural needs and firmer commodity prices. Institutional buying and basic materials cycles added up, though late-quarter weakness trimmed the upside. In my view, macro elements like input cost inflation and U.S. agriculture growth expectations created a favorable setting.

Tools I Rely On: Tickeron’s AI Screener

In my research, I often turn to Tickeron’s AI Screener, an AI-powered tool for discovering stocks and ETFs. It lets me filter thousands of assets using technical patterns, fundamentals, trends, volatility, and AI signals—customizing by industry, market cap, indicators, price patterns, and performance metrics. This helps spot trade ideas, trending names, breakouts, and opportunities faster than manual scans. I find it especially useful for digging into sector performance like fertilizers.

What's Next for IPI Investors

Keep an eye on Q1 2026 earnings on May 6, 2026, for insights into potash production, Trio sales, and guidance against shifting fertilizer demand. Watch global potash prices, U.S. agricultural trends, and commodity inflation. The sector's path depends on peers like Nutrien and supply from big producers. Risks include swinging input costs and geopolitical fertilizer disruptions, while growth in oilfield solutions or more asset sales could spark upside. This is important because it could set the tone for near-term moves.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations

Related Ticker: IPI

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


IPI in upward trend: 10-day moving average moved above 50-day moving average on August 10, 2026

The 10-day moving average for IPI crossed bullishly above the 50-day moving average on August 10, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 06, 2026. You may want to consider a long position or call options on IPI as a result. In of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for IPI just turned positive on August 06, 2026. Looking at past instances where IPI's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

IPI moved above its 50-day moving average on August 10, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IPI advanced for three days, in of 275 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IPI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

IPI broke above its upper Bollinger Band on August 10, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IPI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.018) is normal, around the industry mean (1.518). P/E Ratio (33.034) is within average values for comparable stocks, (44.382). IPI's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.249). IPI has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.040). P/S Ratio (1.712) is also within normal values, averaging (1.482).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IPI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock worse than average.

Notable companies

The most notable companies in this group are CF Industries Holding (NYSE:CF), Mosaic Company (The) (NYSE:MOS).

Industry description

The agricultural chemicals sector includes companies that produce chemical products for the agricultural industry applications like crop protection, animal health, biotechnology and pharmaceutical-related products. Some of the largest agricultural chemicals producers include Nutrien Ltd., Corteva Inc., and FMC Corporation.

Market Cap

The average market capitalization across the Chemicals: Agricultural Industry is 10.16B. The market cap for tickers in the group ranges from 14.68K to 54.57B. CTVA holds the highest valuation in this group at 54.57B. The lowest valued company is CGSI at 14.68K.

High and low price notable news

The average weekly price growth across all stocks in the Chemicals: Agricultural Industry was 4%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was -8%. MOS experienced the highest price growth at 13%, while NXTS experienced the biggest fall at -7%.

Volume

The average weekly volume growth across all stocks in the Chemicals: Agricultural Industry was 99%. For the same stocks of the Industry, the average monthly volume growth was 65% and the average quarterly volume growth was 43%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 36
P/E Growth Rating: 58
Price Growth Rating: 54
SMR Rating: 81
Profit Risk Rating: 79
Seasonality Score: -24 (-100 ... +100)
View a ticker or compare two or three
IPI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a producer of a potash and langbeinite

Industry ChemicalsAgricultural

Profile
Details
Industry
Other Metals Or Minerals
Address
707 17th Street
Phone
+1 303 296-3006
Employees
485
Web
https://www.intrepidpotash.com
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.